Sitagliptin Combo Study.
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2013
At a glance
- Drugs JNJ 38431055 (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 02 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2010 Planned number of patients changed from 20 to 2 as reported by ClinicalTrials.gov.